Press release content from Accesswire. The AP news staff was not involved in its creation.
Tego Cyber Inc. Appoints New York Based Crescendo Communications as Investor Relations and Corporate Communications Advisor
May 3, 2021 GMT
LAS VEGAS, NV / ACCESSWIRE / May 3, 2021 / Tego Cyber Inc. (OTCQB:TGCB), an emerging cybersecurity threat intelligence company, today announced that it has retained Crescendo Communications, LLC (‘Crescendo ) to provide investor relations and .
LAS VEGAS, NV / ACCESSWIRE / May 3, 2021 / Tego Cyber Inc. (OTCQB:TGCB), an emerging cybersecurity threat intelligence company, today announced that it has retained Crescendo Communications, LLC (‘Crescendo ) to provide investor relations and .
LAS VEGAS, NV / ACCESSWIRE / May 3, 2021 / Tego Cyber Inc. (OTCQB:TGCB), an emerging cybersecurity threat intelligence company, today announced that it has retained Crescendo Communications, LLC (‘Crescendo’) to provide investor relations and corporate communicati
Tego Cyber Inc Appoints New York Based Crescendo Communications as Investor Relations and Corporate Communications Advisor
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Tego Cyber Inc Appoints New York Based Crescendo Communications as Investor Relations and Corporate Communications Advisor
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Origin
On April 15, 2021, the Transplant Act was passed by the U.S. House of Representatives with a resounding majority. The act reauthorized the National Marrow Donor Program for another five years.
The program maintains a database that matches bone marrow donors and cord blood units with people who have serious blood diseases, including leukemia. Cord blood units entail blood taken from a baby’s umbilical cord to help treat leukemia, lymphoma, sickle cell anemia, and other diseases.
While almost all Democrats and Republicans in the House voted in favor of this act, the lone two “nays” stood out, and both came from Republicans. Rep. Marjorie Taylor Greene of Georgia and Rep. Lauren Boebert of Colorado voted against the bill that passed the House in a 415-2 vote.